z-logo
Premium
nmb , a novel gene, is expressed in low‐metastatic human melanoma cell lines and xenografts
Author(s) -
Weterman Marian A. J.,
Ajubi Nasser,
van Dinter Irma M. R.,
Degen Winfried G. J.,
van Muijen Goos N. P.,
Ruiter Dirk J.,
Bloemers Henri P. J.
Publication year - 1995
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.2910600111
Subject(s) - complementary dna , biology , melanoma , cell culture , clone (java method) , microbiology and biotechnology , transfection , suppression subtractive hybridization , cdna library , gene , cancer research , gene expression , metastasis , cancer , genetics
From a subtractive cDNA library, we isolated several cDNA clones which showed differential expression between highly and lowly metastatic human melanoma cell lines. One clone, designated nmb , showed preferential expression in the low‐meta‐static cell lines and was chosen for further characterization. Sequence analysis revealed that this clone represents a novel gene, encoding a putative transmembrane glycoprotein which showed the highest homology to the precursor of pMEL17, a melanocyte‐specific protein. nmb RNA expression was absent in most tumor‐cell lines tested and not restricted to the melanocytic lineage. Transfection of a partial nmb cDNA into a highly metastatic melanoma cell line (BLM) resulted, in 2 of 3 transfectants, in slower subcutaneous tumor growth and, in 1 of 3 transfectants, in reduction of the potential for spontaneous metastasis in nude mice. © 1995 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom